4th Biosimilars Congregation 2014
SGS will be exhibiting at the 4th Biosimilars Congregation 2014 in London, where top representative form pharmaceutical, biotechnology and regulatory organizations will come together to address key issues in the industry.
February 26, 2014
February 27, 2014
London, United Kingdom
This conference will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. Hence, this 4th Biosimilars Congregation 2014 will look at the multiple facets of biosimilars, ranging from the evolving regulatory landscape and challenges in clinical development, to the legal and economic aspects. This Biosimilars conference will focus on multiple aspects of biosimilar product development to successfully deliver safe, biosimilar products to the market place. By attending this conference you will gain a comprehensive outlook on the key issues surrounding biosimilars. This event will provide an important platform for Biosimilars stakeholders to discuss and share best practices in expediting Biosimilars development.
Come along, and meet SGS to discuss your current and future projects. Further details are to be provided shortly.
For more information on this event and to register your place, please visit the 4th Biosimilars Congregation 2014 website.